A novel autoantibody targeting calreticulin is associated with cancer in patients with idiopathic inflammatory myopathies is a research paper published in Clinical & Translational Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01AI069120
National Institutes of Health
Grant: AI078389
National Institutes of Health
Grant: AI056154
National Natural Science Foundation of China
Grant: 81802870
National Natural Science Foundation of China
Grant: 81971531
National Natural Science Foundation of China
Grant: 81590765
National Natural Science Foundation of China
Grant: 91542201
National Natural Science Foundation of China
Grant: 81701615
Beijing Municipal Science and Technology Commission
Grant: Z171100001017208
Natural Science Foundation of Jiangsu Province
Grant: BK20170407
Natural Science Foundation of Jiangsu Province
Grant: BK20161246
Natural Science Foundation of Jiangsu Province
Grant: BK20151253
National Major Science and Technology Projects of China
Grant: 2015ZX09102023
NIAID NIH HHS
Grant: R56 AI078389
NIAID NIH HHS
Grant: R01 AI056154
NIAID NIH HHS
Grant: R01 AI078389
National Institutes of Health
Grant: 2R01AI069120-11A1
Viral Mediated Type I Interferon Induction
National Institutes of Health
Grant: 1R01AI056154-01A1
Mechanisms of Biodefense By Toll-Like Receptors
National Institutes of Health
Grant: 5R01AI078389-04
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
FWCI
0.55
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals